Breo Ellipta (fluticasone furoate/vilanterol)

pCPA File Number: 20832
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0358
pCPA Engagement Letter Issued:
Negotiation Process Concluded: